Table 4.
Annual CT screening vs. no intervention. Sensitivity analyses in cohorts of men age 50.
Scenario | $/QALY compared to no intervention |
---|---|
Base Case* | $149,000 |
| |
70% Adherence to screening | $180,000 |
CT sensitivity = 100% | $141,000 |
Less-costly helical CT ($188, HOPPS) | $120,000 |
Follow up nodules <4mm | $148,000 |
Lower operative mortality (3%, lobectomy; 0.1% mediastinoscopy; 0.2% VATS) | $141,000 |
Delay before return to baseline health after resection: | |
1 month | $147,000 |
6 months | $150,000 |
12 months | $154,000 |
24 months | $161,000 |
No recovery | $209,000 |
Base case values: perfect adherence; CT sensitivity based on diameter; screening CT cost of $283 based on Physician Fee Schedule; no follow-up of nodules <4mm; operative mortality 4% (lobectomy), 0.3% (mediastinoscopy) and 0.5% (VATS); and 3 month recovery after resection. HOPPS, Hospital Outpatient Prospective Payment System; VATS, video-assisted thoracoscopy.